Table 2.
Locations of metastases and responses after two courses of GN therapy.
| CR·PR | SD | PD | Total | |
|---|---|---|---|---|
| Lymph node | 13 (59%) | 7 | 2 | 22 |
| Lung | 4 (57%) | 1 | 2 | 7 |
| Liver | 2 (67%) | 1 | 0 | 3 |
| Bone | 0 (0.0%) | 2 | 0 | 2 |
| Local recurrence | 1 (17%) | 5 | 0 | 6 |
| Urethra | 0 (0.0%) | 1 | 0 | 1 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.